← Leaderboards
Eleni Markoutsa
University Of South Florida
$519,323
Attributed
$519,323
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $369.8K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$519,323 · 2
By mechanism
R01$369,823 · 1
R03$149,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of South Florida
Same institution · by research overlap
- Gary W Arendash$2,217,835
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposMediatingAstrocytesProteinsBrainMicrogliaGenesIn VivoMicrornasProductionCovid-19S Disease RiskPathway InteractionsNeurologic SymptomsLong-Term Effects2019-NcovSars-Cov-2 InfectionInflammationCovid-19 SurvivorsCovid-19 ImpactCovid-19 TherapeuticsAbeta SynthesisAmyloid DepositionCytokine
Grant awards (3)
The role of SARS-CoV-2-induced senescence in the development of Alzheimer's Disease$369,823
R01 · FY2025 · NS · contact PI
MiRNA-based Therapeutics for SARS-CoV-2 S1 mediated neuroinflammation and beta-amyloid production$74,750
R03 · FY2023 · NS · contact PI
MiRNA-based Therapeutics for SARS-CoV-2 S1 mediated neuroinflammation and beta-amyloid production$74,750
R03 · FY2022 · NS · contact PI